Inbiogen Acquires Vident Shares Worth 13.8 Billion KRW... Stake Ratio 15.99%
[Asia Economy Reporter Lee Gwan-ju] Inbiogen announced on the 24th that it acquired 1,411,034 shares of Vident for approximately 13.8 billion KRW. This represents 17.73% of its equity capital, and the shareholding ratio after acquisition is 15.99%. The company stated that the purpose of the acquisition is "business diversification and strengthening management control."
Hot Picks Today
600 Million vs. 460 Million vs. 160 Million... Samsung Electronics DS Division: "Three Paychecks Under One Roof"
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- [Breaking] KOSPI, Buy Sidecar Activated
- "Disappointing Results: 80% of Sunscreens Found Lacking in Safety and Effectiveness"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing Deeply for Your Vote Really Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
